Email
Print
Dronabinol Market Overview
Dronabinol Market size is estimated to reach $351.3 million by 2027, growing at a CAGR of 6.7% during the forecast period 2022-2027. Dronabinol is a cannabinoid utilized for the treatment of nausea, vomiting and appetite loss. Dronabinol brand name includes Marinol and Syndros. The dronabinol price includes the minimum GoodRx price for the most typical version of dronabinol at about $65.31, 72% off the average retail price of $236.86. Dronabinol side effects as reported for Marinol include “seizure, fast or pounding heartbeats and lightheadedness” among other side effects. Dronabinol uses include treating loss of appetite that brings about weight loss in people with Acquired Immunodeficiency Syndrome (AIDS). The rising treatment to cure chronic pain and post-traumatic stress disorder with medications categorized under the dronabinol brand name are set to drive the Dronabinol Market. The potential advantages offered by dronabinol to acute AIDS patients with hunger loss and weight loss are set to propel the growth of the Dronabinol Industry during the forecast period 2022-2027. This represents the Dronabinol Industry Outlook.
Dronabinol Market Report Coverage
The report: “Dronabinol Market Report - Forecast
(2022-2027)” by IndustryARC, covers an in-depth analysis of the following
segments in the Dronabinol
Market.
By Type: Oral Liquid, Capsule and Others.
By Application: Anti-Nausea, Analgesic, Stimulate Appetite and Others.
By Geography: North America (the U.S., Canada and Mexico), Europe (Germany, France, UK,
Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South
Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South
America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest Of
The World (the Middle East and Africa).
Key Takeaways
- Geographically, North America accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the great predominance of nausea connected with cancer chemotherapy in the North American region.
- Dronabinol Market growth is being driven by the increasing application of medications with the dronabinol brand name to enhance appetite in AIDs patients. However, the dronabinol side effects causing anxiety and panic attacks relying on the doses of patients and individual inclinations are some of the major factors hampering the growth of the Dronabinol Market.
- Dronabinol Market Detailed Analysis of the Strengths, Weaknesses and Opportunities of the prominent players operating in the market will be provided in the Dronabinol Market report.
Dronabinol Market: Market Share (%) by Region, 2021
For more details on this report - Request for Sample
Dronabinol Market Segment Analysis - By Type
The Dronabinol Market based on type can be further segmented into Oral Liquid, Capsule and Others. The Oral Liquid Segment held the largest Dronabinol market share in 2021. This growth is owing to the approval of Dronabinol by the U.S. Food and Drug Administration (FDA) for the treatment of nausea connected with cancer chemotherapy and for the treatment of anorexia connected with weight loss in AIDS patients. The effortless-to-swallow administration alternative pertaining to Dronabinol oral solution formulation is further propelling the growth of the Oral Liquid segment. Furthermore, the Capsule segment is estimated to grow with the fastest CAGR of 7.3% during the forecast period 2022-2027 owing to the dronabinol uses of capsules being to assist patients to consume more and for the treatment of disturbed stomach and nauseous.
Dronabinol Market Segment Analysis - By Application
The Dronabinol Market based on the application can be further segmented into Anti-Nausea, Analgesic, Stimulate Appetite and Others. The Anti-Nausea Segment held the largest Dronabinol market share in 2021. This growth is owing to the increasing dronabinol uses for treating serious nausea and vomiting brought about by cancer chemotherapy. Dronabinol price needs to be considered and dronabinol side effects need to be kept track of. The correct dosage of dronabinol capsules and solution to be utilized to treat nausea and vomiting brought about by chemotherapy are to be followed and this is further propelling the growth of this segment. Furthermore, the Stimulate Appetite segment is estimated to grow with the fastest CAGR of 7.5% during the forecast period 2022-2027 owing to dronabinol uses to enhance appetite by treating loss of appetite that brings about weight loss in AIDS patients and dronabinol price.
Dronabinol Market Segment Analysis - By Geography
The Dronabinol Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Dronabinol Market) held the largest Dronabinol market share with 45% of the overall market in 2021. The growth of this region is owing to the increasing predominance of AIDS in countries like the U.S. in the North American region. The existence of key players like Merck & Co., Inc. is further propelling the growth of the Dronabinol Industry, thereby contributing to the growth of the Dronabinol Industry Outlook, in the North American region. Furthermore, the Rest Of The World region is estimated to be the region with the fastest CAGR over the forecast period 2022-2027. This growth is owing to factors like the increasing predominance of AIDS in Southern Africa in the Rest Of The World region. The rising application of medications categorized under the dronabinol brand name to enhance appetite in AIDS patients is further fuelling the progress of the Dronabinol Market in the Rest Of The World region.
Dronabinol Market Drivers
Increasing Applications of Dronabinol is Projected to Drive the Growth of the Dronabinol Market:
Dronabinol is a man-made form of tetrahydrocannabinol (THC), a psychoactive substance discovered in cannabis (also termed marijuana). Dronabinol capsules categorized under the dronabinol brand name are designated in adults for the treatment of anorexia connected with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS) and for nausea and vomiting connected with cancer chemotherapy in patients who have been unsuccessful in responding sufficiently to traditional antiemetic treatments. The recommended adult starting dosage of Dronabinol capsules is 2.5 mg orally twice every day, one hour prior to lunch and dinner. The increasing applications of Dronabinol are therefore fuelling the growth of the Dronabinol Industry, thereby contributing to the Dronabinol Industry Outlook during the forecast period 2022-2027.
Increasing Predominance of AIDS is Expected to Boost the Growth of the Dronabinol Industry:
As per World Health Organization (WHO), in 2021, 650 000 [510 000–860 000] people lost their lives from HIV-connected causes and 1.5 million (1.1–2.0 million) people acquired HIV. Dronabinol is applied in the treatment of loss of appetite which brings about weight loss in AIDS patients. Subsequent to oral administration, Dronabinol has an outbreak of activity of nearly 0.5 to 1 hour and peak impact at 2 to 4 hours. Duration of activity for psychoactive impacts is 4 to 6 hours, however, the appetite stimulant impact of Dronabinol may continue for 24 hours or greater subsequent to administration. The increasing predominance of AIDS is therefore driving the growth of the Dronabinol Market during the forecast period 2022-2027.
Dronabinol Market Challenge
Side Effects of Dronabinol are Hampering the Growth of the Dronabinol Market:
Dronabinol is not approved for application by anyone younger than 18 years old. Dronabinol's side effects include signs of an allergic reaction like mouth sores. One should not utilize dronabinol capsules if one is allergic to sesame oil. One should not utilize dronabinol oral solution if one has had an allergic reaction to alcohol or if one also utilizes disulfiram (Antabuse) or metronidazole (Flagyl). Dronabinol can increase or decrease blood pressure, specifically in older adults or in people with heart issues These issues are thus hampering the growth of the Dronabinol Market.
Dronabinol Industry Outlook
Novel product launches, acquisitions and collaborations are key strategies adopted by players in the Dronabinol Market. The top 10 companies in the Dronabinol market are:
- LGC Group
- Merck & Co. Inc.
- Alfa Chemistry
- Aurora Fine Chemicals
- ZINC
- ChemSpace
- Avantor Inc.
- ChemFaces
- Insys Technologies
- Noramco Inc.
Recent Developments
- In June 2022, Merck declared the introduction of the Merck Digital Sciences Studio (MDSS). This was performed to allow the production of innovative technologies for drug discovery and development. MDSS will back early-stage biomedical startups with direct investment.
- In November 2021, Merck declared the successful finishing of the acquisition of Acceleron Pharma Inc. Acceleron is directed on reining in the power of the converting growth factor (TGF)-beta superfamily of protein. These are recognized to play a principal role in the organization of cell growth, distinction and restoration.
- In April 2021, Merck declared the successful finishing of the cash tender offer, by way of a subsidiary, for all of the outstanding shares of common stock of Pandion Therapeutics, Inc. This was performed at a purchase price of $60 per share. As of the tender offer expiration, 27,770,123 shares of the common stock of Pandion were validly tendered.
Relevant Reports:
Chemotherapy-Induced
Myelosuppression Treatment Market - Industry Analysis, Market Size, Share,
Trends, Application Analysis, Growth and Forecast Analysis
Report
Code: HCR 90529
Weight
Loss And Weight Management Diet Market - Industry Analysis, Market Size, Share,
Trends, Application Analysis, Growth and Forecast Analysis
Report Code: FBR 30004
Appetite
(Eating) Disorders Market - Industry Analysis, Market Size, Share, Trends,
Application Analysis, Growth and Forecast Analysis
Report Code:
HCR 0611
For more Lifesciences and Healthcare related reports, please click here